1-4 of 4
Sharyne M. Donfield, PhD
Close
Sort by
Journal Articles

Prompt Immune Tolerance Induction at Inhibitor Diagnosis Regardless of Titer May Increase Overall Success in Hemophilia A With Inhibitors: Experience of Two US Centers

Charles T Nakar, MD, Marilyn J. Manco-Johnson, MD, Alice Lail, MPH, Sharyne M. Donfield, PhD, Jennifer Maahs, MSN PNP, Young Chong, RN, Taylor A Blades, BS, Amy D. Shapiro, MD
Journal: Blood
Blood (2013) 122 (21): 575.
https://doi.org/10.1182/blood.V122.21.575.575
Published: 2013
Journal Articles

Genetic Factors Associated with Inhibitor Development in Hemophilia A: Initial Results From the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Jan Astermark, MD, PhD, John Schwarz, MA, Sharyne M. Donfield, PhD, Donna M. DiMichele, MD, Bruce M. Ewenstein, MD, PhD, Edward D. Gomperts, MD, George W. Nelson, PhD, Johannes Oldenburg, MD, PhD, Amy D. Shapiro, MD, Gerald Spotts, PhD, Cheryl A. Winkler, PhD, Erik Berntorp, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 217.
https://doi.org/10.1182/blood.V114.22.217.217
Published: 2009
Journal Articles

Association between a History of Inhibitors and Delays in Skeletal Maturation in Adolescents with Hemophilia.

Sharyne M. Donfield, PhD, Alice Lail, M.P.H., Edward D. Gomperts, M.D., W. Keith Hoots, M.D., Erik Berntorp, M.D., Ph.D., Henry S. Lynn, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1022.
https://doi.org/10.1182/blood.V108.11.1022.1022
Published: 2006
Journal Articles

Health-Economic Analysis of Alternative Bypassing Agents in Haemophilia Complicated by an Inhibitor - the FEIBA® NovoSeven® Comparative Study (FENOC).

Katarina Steen Carlsson, PhD, Jan Astermark, PhD, MD, Sharyne M. Donfield, PhD, Erik Berntorp, MD
Journal: Blood
Blood (2006) 108 (11): 457.
https://doi.org/10.1182/blood.V108.11.457.457
Published: 2006